Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 14 of 15

Slide 14
Back to 13
Continue to 15
 
Back to 13
Continue to 15
 

Legend Biotech (NASDAQ:LEGN)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
13 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$80.62 (113.9% Upside)

About Legend Biotech

Legend Biotech logoLegend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/21/2025HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
12/30/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$78.00 ➝ $78.00
12/10/2024HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
12/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$83.00 ➝ $83.00
12/9/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$86.00 ➝ $86.00
11/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
10/29/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$86.00 ➝ $86.00
10/16/2024HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
10/8/2024Redburn AtlanticInitiated CoverageBuy$86.00
9/30/2024HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
Slide 14
Back to 13
Continue to 15
 

More From MarketBeat
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
7 Gene Editing Stocks Offering Transformational Change
Investors are talking about the impact that artificial intelligence (AI) can have on their portfolios. But the...
MarketBeat
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
7 Small-Cap Robinhood Stocks Millennials and Gen Z Are Betting On
Robinhood Markets Inc. (NASDAQ: HOOD) is one of the more popular sites for retail investors. In 2024, approx...
MarketBeat
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...
Brownstone Research | Sponsored
7 Consumer Discretionary Stocks That Will Continue to Rally
Consumer discretionary stocks appear to be among the winners from the ongoing Trump trade following the U.S. p...
MarketBeat